Publications by authors named "Naoki Shingai"

Claim this Profile
P
Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantation.
Yasutaka Sadaga, Daisuke Watanabe, Yuho Najima, Daichi Sadato, Chizuko Hirama, Naoki Shingai

Hematology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCT-VTE-J Model to Predict Late-Onset Venous Thromboembolism after Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Single-Center Study.
Shuhei Kurosawa, Kana Kato, Yasutaka Sadaga, Kaori Kondo, Satoshi Sakai, Naoki Shingai

Transplant Cell Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Effectiveness and safety of ibrutinib for steroid-dependent/refractory chronic graft-versus-host disease: a single-center analysis].
Fumihiko Ouchi, Yuho Najima, Kana Kato, Kaori Kondo, Yasutaka Sadaga, Naoki Shingai

Rinsho Ketsueki· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved non-relapse mortality in allogeneic hematopoietic stem cell transplantation: a long-standing multidisciplinary pursuit at a single center.
Shuhei Kurosawa, Kairi Kojo, Riki Yamakawa, Kana Kato, Yasutaka Sadaga, Naoki Shingai

Bone Marrow Transplant· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning Algorithm to Explore Patients With Heterogeneous Treatment Effects of Clinically Significant CMV Infection and Non-Relapse Mortality After HSCT.
Takashi Toya, Yujiro Nakajima, Konan Hara, Satoshi Kaito, Tetsuya Nishida, Naoki Shingai

EJHaem· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-transplant blinatumomab and/or inotuzumab ozogamicin therapy for relapsed/refractory acute lymphoblastic and B/myeloid mixed phenotype acute leukemia in adults.
Kaori Kondo, Yuho Najima, Daichi Sadato, Chizuko Hirama, Kana Kato, Naoki Shingai

Leuk Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in donor lymphocyte infusion for relapsed patients post-hematopoietic stem cell transplantation: a 30-year single-center experience.
Yusuke Uchibori, Shuhei Kurosawa, Yuho Najima, Kyoko Haraguchi, Daichi Sadato, Naoki Shingai

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-induced liver injury due to granulocyte colony-stimulating factor in a healthy donor for allogeneic peripheral blood stem cell transplantation.
Kana Kato, Shuhei Kurosawa, Riki Yamakawa, Kairi Kojo, Yasutaka Sadaga, Naoki Shingai

Vox Sang· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Dermatopathic lymphadenopathy in chronic skin graft-versus-host disease].
Kana Kato, Takeshi Kobayashi, Tsunekazu Hishima, Kaori Kondo, Yasutaka Sadaga, Naoki Shingai

Rinsho Ketsueki· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of DTaP-IPV and DTaP Vaccination Among Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Prospective Observational Study.
Taiichiro Kobayashi, Sho Fujiwara, Ayako Ide, Takashi Toya, Naoki Shingai

Vaccines (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quizartinib with donor lymphocyte infusion for post-transplant relapse of FLT3-ITD-positive acute myeloid leukemia.
Fumihiko Ouchi, Naoki Shingai, Yuho Najima, Daichi Sadato, Chizuko Hirama

Int J Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies.
Satoshi Kaito, Yuho Najima, Daichi Sadato, Chizuko Hirama, Yuya Kishida, Naoki Shingai

Bone Marrow Transplant· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HMGA2 promotes platelet-neutrophil complex formation and pulmonary tissue damage in myelodysplastic syndromes.
Natsumi Matsunuma, Yoshihiro Hayashi, Marina Fukuda, Kanako Yuki, Yasushige Kamimura-Aoyagi, Naoki Shingai

Blood Vessel Thromb Hemost· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy.
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Sotaro Goto, Yasuhiko Yamamura, Naoki Shingai

J Clin Exp Hematop· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine Learning Prediction Model for Neutrophil Recovery after Unrelated Cord Blood Transplantation.
Yachiyo Kuwatsuka, Rika Kasajima, Rui Yamaguchi, Naoyuki Uchida, Takaaki Konuma, Naoki Shingai

Transplant Cell Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Analysis of Allogeneic Bone Marrow Transplantation Outcomes Between Japanese and Non-Japanese Populations.
Ryu Yanagisawa, Michiho Shindo, Akihito Shinohara, Yachiyo Kuwatsuka, Koichi Nakase, Naoki Shingai

Transplant Proc· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[FLT3-ITD mutation-positive acute myeloid leukemia undergoing clonal transition with PTPN11 mutation at relapse].
Kazuya Kurihara, Daichi Sadato, Yuho Najima, Chizuko Hirama, Kyoko Haraguchi, Naoki Shingai

Rinsho Ketsueki· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ruptured mycotic cerebral aneurysm in an adult T-cell leukemia/lymphoma patient undergoing allogeneic stem cell transplantation].
Satoshi Koi, Hiroaki Shimizu, Yasutaka Sadaga, Kaori Kondo, Chika Kato, Naoki Shingai

Rinsho Ketsueki· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of individual comorbidities with outcomes in allogeneic hematopoietic cell transplantation from unrelated adult donors versus unrelated cord blood: A study on behalf of the Donor/Source and Transplant Complications Working Groups of the Japanese Society for Transplantation and Cellular Therapy.
Takaaki Konuma, Kaito Harada, Akihito Shinohara, Naoyuki Uchida, Naoki Shingai

Am J Hematol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Kidney transplantation for end-stage renal disease after third allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia].
Akihiko Nishijima, Naoki Shingai, Akihito Ohta, Kiyoko Suda, Kazuya Omoto

Rinsho Ketsueki· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevation of Urinary Liver-Type Fatty Acid-Binding Protein Is a Harbinger of Poor Patient Prognosis after Allogeneic Stem Cell Transplantation.
Naoki Shingai, Akihito Ota, Kana Kato, Kaori Kondo, Yasutaka Sadaga

Transplant Cell Ther· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Immune pressure on hematopoietic stem cells can drastically expand glycosylphosphatidylinositol-deficient clones in paroxysmal nocturnal hemoglobinuria.
Naoki Shingai, Hiroki Mizumaki, Yuho Najima, Yuta Yamada, Dung Cao Tran

Front Immunol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma after second-line salvage chemotherapy: A retrospective study.
Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Mina Sei, Takuma Matsuo, Naoki Shingai

Cancer Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Polatuzumab vedotin, bendamustine, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma, including the outcome as a bridging treatment to CAR-T cell therapy or allogeneic hematopoietic stem cell transplant].
Yuka Morita, Yu Yagi, Yusuke Kanemasa, Yuki Sasaki, Kento Ishimine, Naoki Shingai

Rinsho Ketsueki· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of Donor Lymphocyte Infusion and Blinatumomab for B-Cell Lymphoblastic Lymphoma Relapse after Allogeneic Stem-Cell Transplantation.
Jinichi Mori, Naoki Shingai, Takeshi Kobayashi, Noriko Doki

Case Rep Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis